CV Risk Not Increased With Gender-Affirming Hormone Therapy Use in Transgender Women

WEDNESDAY, Nov. 12, 2025 (HealthDay News) -- Gender-affirming hormone therapy use is associated with increased cardiovascular risk among transgender men but not